299 related articles for article (PubMed ID: 29341581)
1. Functional Chitosan Nanoparticles in Cancer Treatment.
Fu S; Xia J; Wu J
J Biomed Nanotechnol; 2016 Aug; 12(8):1585-603. PubMed ID: 29341581
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
3. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
4. Optimization of Transforming Growth Factor-β1 siRNA Loaded Chitosan-Tripolyphosphate Nanoparticles for the Treatment of Colorectal Cancer Hepatic Metastasis in a Mouse Model.
Fang JK; Chen L; Lu XG; Cao D; Guo LL; Zhang YS; Li LB; Zhang LF; Kuang YT; Wang SL
J Biomed Nanotechnol; 2016 Jul; 12(7):1489-1500. PubMed ID: 29337488
[TBL] [Abstract][Full Text] [Related]
5. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based nanocarriers for encapsulation and delivery of curcumin: A review.
Hu Q; Luo Y
Int J Biol Macromol; 2021 May; 179():125-135. PubMed ID: 33667554
[TBL] [Abstract][Full Text] [Related]
7. Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery.
Sarvaiya J; Agrawal YK
Int J Biol Macromol; 2015 Jan; 72():454-65. PubMed ID: 25199867
[TBL] [Abstract][Full Text] [Related]
8. Chitosan nanopolymers: An overview of drug delivery against cancer.
Shanmuganathan R; Edison TNJI; LewisOscar F; Kumar P; Shanmugam S; Pugazhendhi A
Int J Biol Macromol; 2019 Jun; 130():727-736. PubMed ID: 30771392
[TBL] [Abstract][Full Text] [Related]
9. Advances in chitosan-based nanoparticles for oncotherapy.
Zhang E; Xing R; Liu S; Qin Y; Li K; Li P
Carbohydr Polym; 2019 Oct; 222():115004. PubMed ID: 31320066
[TBL] [Abstract][Full Text] [Related]
10. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
Tian B; Hua S; Liu J
Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
[TBL] [Abstract][Full Text] [Related]
11. Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications.
Gao Y; Wu Y
Int J Biol Macromol; 2022 Apr; 203():379-388. PubMed ID: 35104473
[TBL] [Abstract][Full Text] [Related]
12. Advances and Potential Applications of Chitosan Nanoparticles as a Delivery Carrier for the Mucosal Immunity of Vaccine.
Li D; Fu D; Kang H; Rong G; Jin Z; Wang X; Zhao K
Curr Drug Deliv; 2017; 14(1):27-35. PubMed ID: 27494157
[TBL] [Abstract][Full Text] [Related]
13. Chitosan and chitosan coating nanoparticles for the treatment of brain disease.
Yu S; Xu X; Feng J; Liu M; Hu K
Int J Pharm; 2019 Apr; 560():282-293. PubMed ID: 30772458
[TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-Based Nanomaterials for Drug Delivery.
Li J; Cai C; Li J; Li J; Li J; Sun T; Wang L; Wu H; Yu G
Molecules; 2018 Oct; 23(10):. PubMed ID: 30332830
[TBL] [Abstract][Full Text] [Related]
16. Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.
Duceppe N; Tabrizian M
Expert Opin Drug Deliv; 2010 Oct; 7(10):1191-207. PubMed ID: 20836623
[TBL] [Abstract][Full Text] [Related]
17. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-based nanoparticles for tumor-targeted drug delivery.
Prabaharan M
Int J Biol Macromol; 2015 Jan; 72():1313-22. PubMed ID: 25450550
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
